Keyphrases
Inhalational Steroids
33%
Transdermal Drugs
30%
Chronic Gastritis
23%
Promoter Polymorphism
18%
Rabeprazole
18%
Tuberculous Pleural Effusion
18%
Cimetidine
18%
Gastric Lesions
18%
Healing
18%
Pranlukast Hydrate
18%
Sucralfate
18%
Hydroxyproline Content
18%
Ehlers-Danlos Syndrome
18%
Direct Superior Approach
18%
Balloon Test Occlusion
18%
Transvenous Embolization
18%
Clinical Significance
18%
Superior Ophthalmic Vein
18%
Carotid-cavernous Fistula
18%
Carotid Stenting
18%
Persistent Trigeminal Artery
18%
Pulmonary Immunity
18%
Growth Marker
18%
Ligand Interaction
18%
Tulobuterol
18%
Airway Hypersensitivity
18%
Tulobuterol Patch
18%
Bronchial Asthma
18%
Refractory Asthma
18%
Fractional Exhaled NO
18%
Collagen Degradation Products
18%
Nrf2 Gene
18%
Primary Lung Cancer
18%
Extraesophageal Symptoms
18%
Japanese Workers
18%
Cervical Carotid Artery
18%
Clinical Evaluation
18%
Pranlukast
18%
Pulmonary Sarcoidosis
18%
Type II Respiratory Failure
18%
MiR-27a
18%
Serum Assay
18%
CYFRA 21-1
18%
Gastric mucosal Atrophy
18%
Male Subjects
18%
Misoprostol
18%
Granulation Tissue
18%
Delayed Maturation
18%
Modified Balloon
18%
Nemaline Myopathy
18%
CT-guided
18%
Promoter Hypomethylation
18%
Tumor Marker
18%
Omeprazole
18%
Initial Antibiotics
18%
DNA Virome
18%
Helicobacter Pylori Infection
18%
Bronchial Responsiveness
18%
Tiotropium
18%
Addition Effect
18%
Inhaler
18%
Severe Tuberculosis
18%
Symptomatic COVID-19
18%
Legionella Pneumophila Pneumonia
18%
Legionella Pneumonia
18%
Alpha-fetoprotein
18%
Automated Description
18%
Description Generation
18%
Cell Growth
18%
Signaling Activation
18%
Unveiling
18%
Hippo
18%
Mesothelioma Cells
18%
Endobronchial Valves
18%
Bronchoscopic Lung Volume Reduction
18%
Yes-associated Protein 1 (YAP1)
14%
Antral Biopsy
12%
SNP
12%
Gene Polymorphism
12%
Genotype
12%
Inhaler Use
12%
Mononuclear Cell Infiltration
12%
Biopsy Specimen
12%
Dissection Aneurysm
11%
Airway Responsiveness
11%
Mesothelioma
10%
Hydroxyproline
10%
Chronic Pulmonary Aspergillosis
10%
Dmin
10%
Hyperacute
9%
Intravenous Tissue Plasminogen Activator
9%
Human Virome
9%
Anellovirus
9%
Small Rodents
9%
Pet Keeping
9%
Pulmonary Cytology
9%
Peptic Ulcer
8%
Mucosal Atrophy
8%
Gastric Malignancy
8%
Updated Sydney System
8%
Medicine and Dentistry
Lung Cancer
58%
Endobronchial Ultrasonography
36%
Artery
29%
Non Small Cell Lung Cancer
25%
Silo-Filler's Disease
20%
Peripheral Lung Lesion
19%
Transbronchial Biopsy
18%
Bone Metastasis
18%
Carotid Artery Stenting
18%
Legionella
18%
Legionella pneumophila
18%
Ophthalmic Vein
18%
Ehlers Danlos Syndrome
18%
Aneurysm
18%
Carotid-Cavernous Fistula
18%
Lung Emphysema
18%
Collagen Degradation
18%
Fetoprotein
18%
Intracranial Aneurysm
18%
Embolization
18%
Spiral Computed Tomography
18%
Skull Base Tumor
18%
microRNA
18%
Chronic Gastritis
18%
Nemaline Myopathy
18%
Pulmonary Sequestration
18%
Dissecting Aneurysm
18%
Collagen Type 1
18%
Thorax Tumor
18%
Proteinase Activated Receptor 2
18%
Internal Carotid Artery
18%
Misoprostol
18%
Granulation Tissue
18%
Thromboxane A2
18%
Eosinophil Cationic Protein
18%
Infectious Complication
18%
Lung
18%
Cytotechnology
18%
Perioperative Period
18%
Evaluation Procedure
18%
Endobronchial Valve
18%
Cardiotoxicity
18%
Osimertinib
18%
Ultrasonography
18%
Cytokeratin 19 Fragment
15%
Infection
13%
Transdermal
12%
Immune Checkpoint Inhibitor
12%
Tumor Marker
10%
QT Prolongation
10%
Metaplasia
9%
Jejunum Ulcer
9%
Metabolite
8%
Chronic Pulmonary Aspergillosis
8%
Squamous Cell Carcinoma
7%
Surgeon
7%
Carcinoembryonic Antigen
7%
Sensitivity and Specificity
7%
Growth Factor Receptor
7%
Invasive Diagnostics
6%
Side Effect
6%
Patient Selection
6%
Molecularly Targeted Therapy
6%
Preoperative Treatment
6%
Anticancer Drug
6%
Immunotherapy
6%
Cytotoxic Chemotherapy
6%
Recurrent Disease
6%
Recurrence Risk
6%
Cancer Staging
5%
Patient Characteristics
5%
Multivariate Analysis
5%
Cancer Treatment
5%
Neoplasm
5%
Collagen Type 3
5%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
100%
Lung Cancer
72%
Eosinophil Cationic Protein
59%
Pranlukast
36%
Transdermal
31%
Tumor Marker
29%
Lung Disease
27%
Cohort Study
21%
Clinical Trial
21%
Respiratory Tract Inflammation
20%
Clinical Study
18%
Suplatast Tosylate
18%
Bone Metastasis
18%
Sucralfate
18%
Hydroxyproline
18%
Rabeprazole
18%
Lung Emphysema
18%
Stomach Lesion
18%
Cimetidine
18%
Vasculotropin
18%
Tulobuterol
18%
Tumor Growth
18%
Antibiotic Agent
18%
Antibiotics
18%
Collagen Type 1
18%
Lung Sarcoidosis
18%
Thromboxane A2
18%
Proteinase Activated Receptor 2
18%
Thorax Tumor
18%
Misoprostol
18%
Granulation Tissue
18%
Respiratory Tract Allergy
18%
Fetoprotein
18%
Chlamydial Pneumonia
18%
Osimertinib
18%
Cardiotoxicity
18%
Cytokeratin 19 Fragment
17%
Carcinoembryonic Antigen
15%
Normal Human
15%
Symptom
15%
Bronchiolitis
12%
QT Prolongation
10%
Squamous Cell Carcinoma
9%
Chronic Obstructive Lung Disease
9%
Mediastinum Tumor
9%
Neuron Specific Enolase
9%
Sialyl Lewis X Antigen
9%
Lung Aspergillosis
8%
Growth Factor Receptor
7%
Non Small Cell Lung Cancer
7%
Allergic Asthma
6%
Small Cell Carcinoma
6%
Tissue Polypeptide Antigen
6%
Adverse Event
5%
Adenocarcinoma
5%
Inflammation
5%
Procollagen Proline 2 Oxoglutarate 4 Dioxygenase
5%
Collagen Type 3
5%